Awareness, Treatment, and Control of Hypertension Among 10663 Adults Based on the Baseline Data of the Kherameh Cohort Study

Overview

Journal J Tehran Heart Cent

Publisher Tehran University of Medical Sciences

Specialty Cardiology & Vascular Diseases

Date 2023 Aug 28

PMID 37637280

Authors

Abbas Rezaianzadeh

Fatemeh Jafari

Masoumeh Ghoddusi Johari

Hamed Karami

Affiliations

Soon will be listed here.

Abstract

Background: A comprehensive strategy to reduce the complications of hypertension (HTN) should include prevention approaches, such as increasing awareness, early diagnosis, and adequate treatment. The present study aimed to assess awareness, treatment, and control of HTN and their related factors in Kherameh, Iran.

Methods: This cross-sectional study was performed on 10 663 individuals aged between 40 and 70 years using the Kherameh cohort data. HTN was defined as either systolic/diastolic blood pressure ≥140/90 mmHg or taking medications. Logistic regression was used to investigate the relationship between awareness, treatment, and control of HTN and demographic factors, comorbidities, and a family history of diseases.

Results: Out of 10 663 participants, 4719 (44.3%) were men, and the average age of the participants was 51.94±8.27 years. The rates of the prevalence, awareness, treatment, and control of HTN were 27.7% (95% CI, 26.86 to 28.54), 80.3% (95% CI, 79.56 to 81.04), 78% (95% CI, 77.22 to 78.78), and 53.6% (95% CI, 52.66 to 54.54), respectively. Age, gender, body mass index, and cardiovascular disease were associated with all the dependent variables in the regression model. Additionally, occupation, diabetes, chronic diseases, a history of cardiovascular disease in first and second-degree relatives and a history of chronic diseases in second-degree relatives were related to all the dependent variables except for treatment.

Conclusion: A high percentage of the patients were aware of their disease, but a smaller proportion were on medication. Consequently, about half the patients had blood pressure below 140/90 mmHg.

References

Bahrami H, Sadatsafavi M, Pourshams A, Kamangar F, Nouraei M, Semnani S . Obesity and hypertension in an Iranian cohort study; Iranian women experience higher rates of obesity and hypertension than American women. BMC Public Health. 2006; 6:158. PMC: 1533819. DOI: 10.1186/1471-2458-6-158. View

Ataklte F, Erqou S, Kaptoge S, Taye B, Echouffo-Tcheugui J, Kengne A . Burden of undiagnosed hypertension in sub-saharan Africa: a systematic review and meta-analysis. Hypertension. 2014; 65(2):291-8. DOI: 10.1161/HYPERTENSIONAHA.114.04394. View

Katulanda P, Ranasinghe P, Jayawardena R, Constantine G, Rezvi Sheriff M, Matthews D . The prevalence, predictors and associations of hypertension in Sri Lanka: a cross-sectional population based national survey. Clin Exp Hypertens. 2014; 36(7):484-91. DOI: 10.3109/10641963.2013.863321. View

Kearney P, Whelton M, Reynolds K, Muntner P, Whelton P, He J . Global burden of hypertension: analysis of worldwide data. Lancet. 2005; 365(9455):217-23. DOI: 10.1016/S0140-6736(05)17741-1. View

Naghavi M, Shahraz S, Sepanlou S, Dicker D, Naghavi P, Pourmalek F . Health transition in Iran toward chronic diseases based on results of Global Burden of Disease 2010. Arch Iran Med. 2014; 17(5):321-35. DOI: 0141705/AIM.005. View

Poustchi H, Eghtesad S, Kamangar F, Etemadi A, Keshtkar A, Hekmatdoost A . Prospective Epidemiological Research Studies in Iran (the PERSIAN Cohort Study): Rationale, Objectives, and Design. Am J Epidemiol. 2017; 187(4):647-655. PMC: 6279089. DOI: 10.1093/aje/kwx314. View

Wang J, Zhang L, Wang F, Liu L, Wang H . Prevalence, awareness, treatment, and control of hypertension in China: results from a national survey. Am J Hypertens. 2014; 27(11):1355-61. PMC: 4263934. DOI: 10.1093/ajh/hpu053. View

Karmakar N, Nag K, Saha I, Parthasarathi R, Patra M, Sinha R . Awareness, treatment, and control of hypertension among adult population in a rural community of Singur block, Hooghly District, West Bengal. J Educ Health Promot. 2018; 7:134. PMC: 6225402. DOI: 10.4103/jehp.jehp_164_18. View

Khanal M, Dhungana R, Bhandari P, Gurung Y, Paudel K . Prevalence, associated factors, awareness, treatment, and control of hypertension: Findings from a cross sectional study conducted as a part of a community based intervention trial in Surkhet, Mid-western region of Nepal. PLoS One. 2017; 12(10):e0185806. PMC: 5628876. DOI: 10.1371/journal.pone.0185806. View

10.

Aghaei Meybodi H, Khashayar P, Rezai Homami M, Heshmat R, Larijani B . Prevalence of hypertension in an Iranian population. Ren Fail. 2013; 36(1):87-91. DOI: 10.3109/0886022X.2013.832315. View

11.

Zhang F, Guo Z, Xing Y, Wu Y, Liu H, Yang Y . Hypertension prevalence, awareness, treatment, and control in northeast China: a population-based cross-sectional survey. J Hum Hypertens. 2017; 32(1):54-65. DOI: 10.1038/s41371-017-0003-4. View

12.

Ezzati M, Lopez A, Rodgers A, Vander Hoorn S, Murray C . Selected major risk factors and global and regional burden of disease. Lancet. 2002; 360(9343):1347-60. DOI: 10.1016/S0140-6736(02)11403-6. View

13.

Oraii A, Shafiee A, Jalali A, Alaeddini F, Saadat S, Sadeghian S . Prevalence, Awareness, Treatment, and Control of Hypertension among Adult Residents of Tehran: The Tehran Cohort Study. Glob Heart. 2022; 17(1):31. PMC: 9104493. DOI: 10.5334/gh.1120. View

14.

Forouzanfar M, Sepanlou S, Shahraz S, Dicker D, Naghavi P, Pourmalek F . Evaluating causes of death and morbidity in Iran, global burden of diseases, injuries, and risk factors study 2010. Arch Iran Med. 2014; 17(5):304-20. DOI: 0141705/AIM.004. View

15.

Lv X, Niu H, Qu Y, Li M, Li L, Ma X . Awareness, treatment and control of hypertension among hypertensive patients aged 18 to 59 years old in the northeast of China. Sci Rep. 2018; 8(1):17019. PMC: 6243001. DOI: 10.1038/s41598-018-34923-5. View

16.

Tian S, Dong G, Wang D, Liu M, Lin Q, Meng X . Factors associated with prevalence, awareness, treatment and control of hypertension in urban adults from 33 communities in China: the CHPSNE Study. Hypertens Res. 2011; 34(10):1087-92. DOI: 10.1038/hr.2011.99. View

17.

Saeed A, Al-Hamdan N, Bahnassy A, Abdalla A, Abbas M, Abuzaid L . Prevalence, Awareness, Treatment, and Control of Hypertension among Saudi Adult Population: A National Survey. Int J Hypertens. 2011; 2011:174135. PMC: 3168271. DOI: 10.4061/2011/174135. View

18.

Rezaianzadeh A, Jafari F, Sadeghi S, Rahimikazerooni S . The prevalence and predictors of pre-hypertension and hypertension in Kherameh cohort study: a population based study on 10,663 persons in south of Iran. J Hum Hypertens. 2020; 35(3):257-264. DOI: 10.1038/s41371-020-0330-8. View

19.

Devkota S, Dhungana R, Pandey A, Bista B, Panthi S, Thakur K . Barriers to Treatment and Control of Hypertension among Hypertensive Participants: A Community-Based Cross-sectional Mixed Method Study in Municipalities of Kathmandu, Nepal. Front Cardiovasc Med. 2016; 3:26. PMC: 4969292. DOI: 10.3389/fcvm.2016.00026. View

20.

Naing C, Yeoh P, Wai V, Win N, Kuan L, Aung K . Hypertension in Malaysia: An Analysis of Trends From the National Surveys 1996 to 2011. Medicine (Baltimore). 2016; 95(2):e2417. PMC: 4718248. DOI: 10.1097/MD.0000000000002417. View